Published in Healthcare Mergers, Acquisitions and Ventures Week, October 15th, 2005
The notes were issued in a private placement and were resold by the initial purchasers to qualified institutional buyers under Rule 144A and Regulation S of the Securities Act of 1933, as amended. The 2012 notes and 2015 notes each were sold at 99.5% of principal amount, resulting in an effective annual interest rate of 5.71% on the 2012 notes and an effective annual interest rate of 5.94% on the 2015 notes.
The gross proceeds from the sale of the notes have been used to finance the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.